Suppr超能文献

射频电不对称输送神经调节治疗抑郁、焦虑和应激障碍

Radio electric asymmetric conveyer neuromodulation in depression, anxiety, and stress.

作者信息

Rinaldi Arianna, Rinaldi Chiara, Coelho Pereira José Alfredo, Lotti Margotti Matteo, Bittencourt Marina Nolli, Barcessat Ana Rita Pinheiro, Fontani Vania, Rinaldi Salvatore

机构信息

Department of Neuro Psycho Physio Pathology and Neuro Psycho Physical Optimization, Rinaldi Fontani Institute, Florence, Italy,

Research Department, Rinaldi Fontani Foundation, Florence, Italy,

出版信息

Neuropsychiatr Dis Treat. 2019 Feb 13;15:469-480. doi: 10.2147/NDT.S195466. eCollection 2019.

Abstract

BACKGROUND

The purpose of this study was to assess the efficacy of specific neuromodulation treatments performed with radio electric asymmetric conveyer (REAC) technology in the treatment of the symptomatic triad depression, anxiety, and stress by the use of a specific psychometric test such as the Depression Anxiety Stress Scale-42 items (DASS-42) version, which assesses simultaneously the severity of expression of this triad.

PATIENTS AND METHODS

The design of this study was planned to compare two populations that performed DASS-42 test twice within a similar period of time. The first population performed the first DASS test before the treatment and the second test about 3 months later, at the end of two specific REAC neuromodulation treatments, neuropostural optimization (NPO) and neuropsychophysical optimization (NPPO), that have previously shown an efficacy in the treatment of depression, anxiety and stress. The second population (untreated), used as the randomized control group, consisted of a similar group by gender and age, who performed the DASS-42 test in an online platform twice, with an interval of about 3 months between the first and second tests, similar to the interval between the two tests in the treated group.

RESULTS

The comparison between the treated group and the control group points out the REAC treatment efficacy in improving the quality of life. At the second DASS-42 test, self-administered about 3 months after the treatments, treated patients were positioned on average values of much milder severity in all the three clusters, depression, anxiety, and stress, while in untreated patients there was no significant difference between the mean values of the first and second DASS tests.

CONCLUSION

The results obtained in this study, evaluated with the DASS-42 test, confirm that REAC-NPO and REAC-NPPO neuromodulation treatments can be useful tools for the clinical treatment of depression, anxiety, and stress, as already proven by previous results evaluated with different psychometric tests.

摘要

背景

本研究的目的是通过使用特定的心理测量测试,如42项抑郁焦虑压力量表(DASS - 42)版本,评估采用射频不对称输送器(REAC)技术进行的特定神经调节治疗对有症状的抑郁、焦虑和压力三联症的疗效,该量表可同时评估这三联症的表达严重程度。

患者与方法

本研究设计为比较在相似时间段内进行两次DASS - 42测试的两组人群。第一组人群在治疗前进行第一次DASS测试,约3个月后,在两种特定的REAC神经调节治疗——神经姿势优化(NPO)和神经心理物理优化(NPPO)结束时进行第二次测试,这两种治疗先前已显示出对抑郁、焦虑和压力的治疗效果。第二组人群(未治疗组)用作随机对照组,由性别和年龄相似的一组人组成,他们在在线平台上进行两次DASS - 42测试,第一次和第二次测试间隔约3个月,与治疗组两次测试的间隔相似。

结果

治疗组与对照组的比较表明REAC治疗在改善生活质量方面的疗效。在治疗约3个月后自行进行的第二次DASS - 42测试中,治疗后的患者在抑郁、焦虑和压力这三个类别中的严重程度平均值均处于明显较轻的水平,而未治疗患者的第一次和第二次DASS测试平均值之间无显著差异。

结论

本研究中用DASS - 42测试获得的结果证实,REAC - NPO和REAC - NPPO神经调节治疗可作为抑郁、焦虑和压力临床治疗的有用工具,正如先前用不同心理测量测试评估的结果所证明的那样。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/00fc/6387613/baf9d3564b4b/ndt-15-469Fig1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验